Global Biobanking Market Size study, By Specimen Type (Blood Products, Solid Tissue, Nucleic Acid, and Cell Lines, Others), Type of Biobank (Population-based Biobanks and Disease-oriented Biobanks), Ownership (National/Regional Agencies, Nonprofit Organization, University, and Private Organization), and Application (Therapeutic and Research), and Regional Forecasts 2020-2027

Get in-depth COVID-19 impact and recovery analysis on the Global Biobanking Market

Flash Discount
15% Single User
20% Multi User
25% Corporate
30% Enterprise
  • Global Biobanking Market is valued approximately at USD 2.08 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 23.7% over the forecast period 2020-2027. Biobanking is a method for gathering and storing biological resources that can be further used for diagnostics, ecosystem studies and analysis. Significant factors driving the growth of the global biobanking industry include expanded financial support from private and government organizations. In addition, an improvement in the prevalence of chronic diseases is driving demand growth. However, ethical and regulatory concerns related to biobanking are restricting business expansion. The emergence of the COVID-19 pandemic has taken the relevance of biobanks across the globe to the forefront. As a result, the rapid establishment of the COVID-19 biobank worldwide has witnessed the prospective selection of research biospecimens and the related clinical and patient data generated by COVID-19 patients with reported infection with the novel SARS-CoV-2 virus to allow high-quality research. For example, NHRI Biobank, Minister of Health and Welfare, was assigned to create a COVID-19 biobank at the beginning of February 2020 to collect blood samples of COVID-19 patients in an evolving way for Taiwanese researchers and industry. Both aspects are projected to have an impact on the biobanking industry in the future. The outbreak of the pandemic has also had a positive impact on the expansion of the biobanking market. Several chronic illnesses, such as cancer, cardiovascular disease, neurological disorders and immunological disorders, cannot be treated with traditional treatment due to adverse side effects. The risk of these side effects may be minimized by incorporating it into stem cell therapy, which serves as a curing agent to mitigate the harm caused by treatment doses. According to figures from the National Cancer Center, about 9.5 million people were confirmed to have cancer in the U.S. in 2019, and this figure is projected to rise to 19 million in 2024. Hence, the demand for cord blood for medicinal purposes, stimulating the development of the biobanking market.

    The regional analysis of global Biobanking Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. Asia-Pacific offers attractive prospects for major players operating in the biobanking industry due to a growth in population and the presence of a large geriatric population base. In addition, the increase in health spending and the developing guidlines are expected to fuel demand growth in the country.

    Major market player included in this report are:

    Thermo Fisher Scientific Inc.

    Panasonic Healthcare Holdings Co., Ltd.

    Becton, Dickinson and Company

    Qiagen N.V.

    Merck KGaA

    VWR Corporation

    Tecan Trading AG

    Brooks Automation, Inc.

    Chart Industries, Inc.

    Hamilton Company

    Greiner Holding AG

    Promega Corporation

    The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-
    segment of the market are explained below:

    By Specimen Type:

    Blood Products

    Solid Tissue

    Cell Lines

    Nucleic Acid


    By Type of Biobank:

    Population-based Biobanks

    Disease-oriented Biobanks

    By Application:



    By Ownership:

    National/Regional Agencies

    Non-profit Organization


    Private Organization

    By Region:

    North America










    Asia Pacific





    South Korea


    Latin America



    Rest of the World

    Furthermore, years considered for the study are as follows:

    Historical year – 2017, 2018

    Base year – 2019

    Forecast period – 2020 to 2027

    Target Audience of the Global Biobanking Market in Market Study:

    Key Consulting Companies & Advisors

    Large, medium-sized, and small enterprises

    Venture capitalists

    Value-Added Resellers (VARs)

    Third-party knowledge providers

    Investment bankers



  • With tables and figures helping analyze worldwide Global Biobanking market, this research provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

    Chapter 1. Executive Summary
    1.1. Market Snapshot
    1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
    1.2.1. Biobanking Market, by Region, 2018-2027 (USD Billion)
    1.2.2. Biobanking Market, by Specimen Type, 2018-2027 (USD Billion)
    1.2.3. Biobanking Market, by Type of Biobank, 2018-2027 (USD Billion)
    1.2.4. Biobanking Market, by Application, 2018-2027 (USD Billion)
    1.2.5. Biobanking Market, by Ownership, 2018-2027 (USD Billion)
    1.3. Key Trends
    1.4. Estimation Methodology
    1.5. Research Assumption
    Chapter 2. Global Biobanking Market Definition & Scope
    2.1. Objective of the Study
    2.2. Market Definition & Scope
    2.2.1. Scope of the Study
    2.2.2. Industry Evolution
    2.3. Years Considered for the Study
    2.4. Currency Conversion Rates
    Chapter 3. Global Biobanking Market Dynamics
    3.1. Biobanking Market Impact Analysis (2018-2027)
    3.1.1. Market Drivers
    3.1.2. Market Challenges
    3.1.3. Market Opportunities
    Chapter 4. Global Biobanking Market: Industry Analysis
    4.1. Porter’s 5 Force Model
    4.1.1. Bargaining Power of Suppliers
    4.1.2. Bargaining Power of Buyers
    4.1.3. Threat of New Entrants
    4.1.4. Threat of Substitutes
    4.1.5. Competitive Rivalry
    4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)
    4.2. PEST Analysis
    4.2.1. Political
    4.2.2. Economical
    4.2.3. Social
    4.2.4. Technological
    4.3. Investment Adoption Model
    4.4. Analyst Recommendation & Conclusion
    Chapter 5. Global Biobanking Market, by Specimen Type
    5.1. Market Snapshot
    5.2. Global Biobanking Market by Specimen Type, Performance - Potential Analysis
    5.3. Global Biobanking Market Estimates & Forecasts by Specimen Type, 2017-2027 (USD Billion)
    5.4. Biobanking Market, Sub Segment Analysis
    5.4.1. Blood Products
    5.4.2. Solid Tissue
    5.4.3. Cell Lines
    5.4.4. Nucleic Acid
    5.4.5. Others
    Chapter 6. Global Biobanking Market, by Type of Biobank
    6.1. Market Snapshot
    6.2. Global Biobanking Market by Type of Biobank, Performance - Potential Analysis
    6.3. Global Biobanking Market Estimates & Forecasts by Type of Biobank, 2017-2027 (USD Billion)
    6.3.1. Population-based Biobanks
    6.3.2. Disease-oriented Biobanks
    Chapter 7. Global Biobanking Market, by Application
    7.1. Market Snapshot
    7.2. Global Biobanking Market by Application, Performance - Potential Analysis
    7.3. Global Biobanking Market Estimates & Forecasts by Application, 2017-2027 (USD Billion)
    7.3.1. Therapeutic
    7.3.2. Research
    Chapter 8. Global Biobanking Market, by Ownership
    8.1. Market Snapshot
    8.2. Global Biobanking Market by Ownership, Performance - Potential Analysis
    8.3. Global Biobanking Market Estimates & Forecasts by Ownership, 2017-2027 (USD Billion)
    8.3.1. National/Regional Agencies
    8.3.2. Non-profit Organization
    8.3.3. University
    8.3.4. Private Organization
    Chapter 9. Global Biobanking Market, Regional Analysis
    9.1. Biobanking Market, Regional Market Snapshot
    9.2. North America Biobanking Market
    9.2.1. U.S. Biobanking Market Specimen Type breakdown estimates & forecasts, 2017-2027 Type of Biobank breakdown estimates & forecasts, 2017-2027 Application breakdown estimates & forecasts, 2017-2027 Ownership breakdown estimates & forecasts, 2017-2027
    9.2.2. Canada Biobanking Market
    9.3. Europe Biobanking Market Snapshot
    9.3.1. U.K. Biobanking Market
    9.3.2. Germany Biobanking Market
    9.3.3. France Biobanking Market
    9.3.4. Spain Biobanking Market
    9.3.5. Italy Biobanking Market
    9.3.6. Rest of Europe Biobanking Market
    9.4. Asia-Pacific Biobanking Market Snapshot
    9.4.1. China Biobanking Market
    9.4.2. India Biobanking Market
    9.4.3. Japan Biobanking Market
    9.4.4. Australia Biobanking Market
    9.4.5. South Korea Biobanking Market
    9.4.6. Rest of Asia Pacific Biobanking Market
    9.5. Latin America Biobanking Market Snapshot
    9.5.1. Brazil Biobanking Market
    9.5.2. Mexico Biobanking Market
    9.6. Rest of The World Biobanking Market
    Chapter 10. Competitive Intelligence
    10.1. Top Market Strategies
    10.2. Company Profiles
    10.2.1. Thermo Fisher Scientific Inc. Key Information Overview Financial (Subject to Data Availability) Industry Summary Recent Developments
    10.2.2. Panasonic Healthcare Holdings Co., Ltd.
    10.2.3. Becton, Dickinson and Company
    10.2.4. Qiagen N.V.
    10.2.5. Merck KGaA
    10.2.6. VWR Corporation
    10.2.7. Tecan Trading AG
    10.2.8. Brooks Automation, Inc.
    10.2.9. Chart Industries, Inc.
    10.2.10. Hamilton Company
    10.2.11. Greiner Holding AG
    10.2.12. Promega Corporation
    Chapter 11. Research Process
    11.1. Research Process
    11.1.1. Data Mining
    11.1.2. Analysis
    11.1.3. Market Estimation
    11.1.4. Validation
    11.1.5. Publishing
    11.2. Research Attributes
    11.3. Research Assumption


  • The Global Biobanking Market has been segregated into various crucial divisions including applications, types, and regions. Each market segment is intensively studied in the report contemplating its market acceptance, worthiness, demand, and growth prospects. The segmentation analysis will help the client to customize their marketing approach to have a better command of each segment and to identify the most prospective customer base.

    Report Objectives / Segmentation Covered :
    By Companies / players:
    • Thermo Fisher Scientific Inc. Panasonic Healthcare Holdings Co.
    • Ltd. Becton
    • Dickinson and Company Qiagen N.V. Merck KGaA VWR Corporation Tecan Trading AG Brooks Automation
    • Inc. Chart Industries
    • Inc. Hamilton Company Greiner Holding AG Promega Corporation
    By Regions:
    • North America
    • U.S.
    • Canada
    • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • ROE
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • RoAPAC
    • Latin America
    • Brazil
    • Mexico
    • Rest of the World
    By Type:
    • of Biobank
    • Population-based Biobanks
    • Disease-oriented Biobanks
    By Application:
    Licensing options

    Need assistance ?

    Related reports

    Research objectives

    Where will all these developments take the industry in the long

    To study and analyze the global Market consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.

    What are the future opportunities in the market?

    To understand the structure of Market by identifying its various subsegments.

    What are the major driving forces expected to impact the development of the market market across different regions?

    To analyze the market with respect to individual growth trends, future prospects, and their contribution to the total market.

    Which industry trends are likely to shape the future of the industry during the forecast period 2020-2025?

    To project the consumption of market submarkets, with respect to key regions.

    Who are the major driving forces expected to decide the fate of the industry worldwide.

    To strategically profile the key players and comprehensively analyze their growth strategies.

    What are the key barriers and threats believed to hinder the development of the industry?

    To analyze competitive developments such as expansions,agreements, new product launches, and acquisitions in the market.

    Who are the prominent market players making a mark in the market with their winning strategies?

    To share detailed information about the key factors influencing the growth of the market

    What will be the growth rate and the market size of the industry for the forecast period 2020-2025?

    Focuses on the key global market Vendors, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

    Our Clients